CYTH — Cyclo Therapeutics Share News
0.000.00%
Last trade - 00:00- $23.04m
- $34.29m
- $1.08m
Cyclo Therapeutics drops on share offering
Brief: Cyclo Therapeutics Says Public Offering Of 1.95 Mln Common Shares Priced At $6 per Share
Brief: Cyclo Therapeutics Announces Proposed Public Offering Of Common Stock
Cyclo Therapeutics jumps on seeking FDA nod for mid-stage Alzheimer's drug trial
Brief: Cyclo Therapeutics Submits Investigational New Drug Application To U.S. FDA
Brief: Cyclo Therapeutics Reports Qtrly Net Loss Per Common Share $0.60
Brief: Cyclo Therapeutics Names Lise Kjems Chief Medical Officer
Brief: Cyclo Therapeutics Qtrly Loss Per Share 56 Cents
Cyclo Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Cyclo Therapeutics Inc - Entered Into An Equity Distribution Agreement To Issue And Sell $20 Million Shares Of Company's Common Stock
Brief: Cyclo Therapeutics Announces Positive Data From Study Of Trappsol Cyclo
Brief: Cyclo Therapeutics Commences Commercial-Scale Manufacturing For Trappsol Cyclo
Cyclo Therapeutics: Rises on launching late-stage study of genetic disorder treatment
Brief: Cyclo Therapeutics Commences Patient Enrollment In Transportnpc, A Pivotal Phase 3 Study Evaluating Trappsol® Cyclo™ In Niemann-Pick Type C1
Brief: Cyclo Therapeutics Announces Launch Of New Website
Brief: Cyclo Therapeutics Announces Inclusion In The Russell 2000 Index
Brief: Cyclo Says On Track To File IND For Phase 2 Study Of Alzheimer's Disease In H2
Brief: Cyclo Therapeutics Announces Design Of Pivotal Phase 3 Study Evaluating Trappsol Cycl In Niemann-Pick Type C1
U.S. STOCKS ON THE MOVE-Nike, Boeing, ViacomCBS, GameStop, Cellect Biotechnology, WISeKey International